Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

In recent years we and others have used the ELISPOT assay successfully to identify novel tumor antigens by the characterization of spontaneous HLA class I restricted immune responses against a number of minimal 9–10 amino acid long peptide epitopes. In the present study, we examined the capability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Stine Kiaer, Hansen, Morten, Svane, Inge Marie, Straten, Per Thor, Andersen, Mads Hald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901095/
https://www.ncbi.nlm.nih.gov/pubmed/24710413
http://dx.doi.org/10.3390/cells1020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901095/
https://www.ncbi.nlm.nih.gov/pubmed/24710413
http://dx.doi.org/10.3390/cells1020051

Ejemplares similares